Content about Vomiting

July 1, 2013

More than half of Americans suffer from motion sickness, according to a recent survey conducted on behalf of Prestige Brands' Dramamine, with as many as 60% indicating that they most often suffer while riding as a passenger in a car.

TARRYTOWN, N.Y. — More than half of Americans suffer from motion sickness, according to a recent survey conducted on behalf of Prestige Brands' Dramamine, with as many as 60% indicating that they most often suffer while riding as a passenger in a car.

Although many — 86% — agree that motion sickness is an unpleasant condition that can spoil travel plans, nearly half (46%) admit that they have no idea how to prevent it. 

May 21, 2013

Drug maker Duchesnay USA has launched a new treatment for morning sickness, the company announced.

ROSEMONT, Pa. — Drug maker Duchesnay USA has launched a new treatment for morning sickness, the company said Tuesday.

May 7, 2013

Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.

CARSON, Calif. — Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.

Street-level displays were strategically placed throughout New York at subway entrances to reach multiple audiences with increased frequency, noted Russ Allison, Sato general manager U.S. 

April 9, 2013

The Food and Drug Administration has approved a drug for treating nausea and vomiting during pregnancy.

ROSEMONT, Pa. — The Food and Drug Administration has approved a drug for treating nausea and vomiting during pregnancy.

Drug maker Duchesnay USA said the FDA approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets in the 10 mg/10 mg strength for NVP, more commonly known as morning sickness, in women who don't respond to conservative treatment. NVP is estimated to affect 70-85% of pregnant women, and symptoms range from nausea to severe vomiting and retching that can last throughout the day.

March 21, 2013

Norovirus has emerged as the leading cause of gastroenteritis - inflammation of the stomach and intestines - in children younger than 5 years, according to a new study.

ATLANTA — Norovirus has emerged as the leading cause of gastroenteritis — inflammation of the stomach and intestines — in children younger than 5 years, according to a new study.

January 24, 2013

A new strain of norovirus from Australia accounts for more than half of outbreaks around the country, according to the Centers for Disease Control and Prevention.

NEW YORK — A new strain of norovirus from Australia accounts for more than half of outbreaks around the country, according to the Centers for Disease Control and Prevention.

September 11, 2012

Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.

 SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched a drug used to treat complications related to chemotherapy, the drug maker said.

The Schaumburg, Ill.-based company announced the launch of ondansetron injection, used to prevent nausea and vomiting associated with emetogenic cancer chemotherapy and also to prevent nausea and vomiting that follows surgery.

Various versions of the drug had sales of $49 million during the 12-month period that ended in June, according to IMS Health.

April 25, 2011

Drug maker AP Pharma has appointed two new executives and may receive financing of up to $4.5 million, the company said Monday.

REDWOOD CITY, Calif. — Drug maker AP Pharma has appointed two new executives and may receive financing of up to $4.5 million, the company said Monday.

AP announced the appointment of John Whelan as president, CEO and director, and Michael Adam as SVP and COO.